SCHEMBL6312840

SCHEMBL6312840

CCCCCCCCCCc1c(C)c(C#N)c2nc3ccccc3n2c1N1CCCC1N(C)C

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.59
KMT2A Q03164 5/20 0.55
NPSR1 Q6W5P4 4/20 0.55
SMN1; SMN2 Q16637 3/20 0.55
RAB9A P51151 3/20 0.55
HPGD P15428 2/20 0.55
MAPT P10636 2/20 0.55
HTT P42858 1/20 0.55
HIF1A Q16665 1/20 0.53
MEN1 O00255 4/20 0.53
ALDH1A1 P00352 6/20 0.53
TSHR P16473 2/20 0.53
CASP1 P29466 1/20 0.53
CASP7 P55210 1/20 0.53
HSD17B10 Q99714 1/20 0.53
SLC2A1 P11166 1/20 0.50
KDM4E B2RXH2 3/20 0.49
GLA P06280 2/20 0.49
GAA P10253 2/20 0.49
RXFP1 Q9HBX9 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Formic Acid SCHEMBL6313185 0.93 NPSR1 (0.55) L3MBTL1KMT2ANPSR1SMN1; SMN2RAB9A
SCHEMBL6311128 0.91 HIF1A (0.56) L3MBTL1KMT2ANPSR1SMN1; SMN2RAB9A
Hydrochloric Acid SCHEMBL6311162 0.90 HIF1A (0.53) L3MBTL1KMT2ANPSR1SMN1; SMN2RAB9A
SCHEMBL6314332 0.88 MEN1 (0.54) KMT2ANPSR1SMN1; SMN2RAB9AHPGD
SCHEMBL6312289 0.87 KMT2A (0.50) L3MBTL1KMT2ANPSR1SMN1; SMN2RAB9A
SCHEMBL6314532 0.86 HIF1A (0.52) L3MBTL1KMT2ANPSR1SMN1; SMN2RAB9A
SCHEMBL6313325 0.86 ALDH1A1 (0.55) L3MBTL1KMT2ANPSR1SMN1; SMN2RAB9A
SCHEMBL6399562 0.86 ALDH1A1 (0.51) L3MBTL1KMT2ANPSR1SMN1; SMN2RAB9A
SCHEMBL6311356 0.85 KMT2A (0.51) L3MBTL1KMT2ANPSR1SMN1; SMN2RAB9A
SCHEMBL6309873 0.85 MEN1 (0.56) KMT2ANPSR1SMN1; SMN2RAB9AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050113397-A1 Imidazo[1,2-a]pyridine derivative DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2005-05-26 US disclosed
EP-1479681-A1 IMIDAZO(1,2-a)PYRIDINE DERIVATIVE DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2004-11-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050113397-A1 Imidazo[1,2-a]pyridine derivative MANBA, MAN2B1, ERG28 L3MBTL1 3913/4885KMT2A 4210/4885NPSR1 1531/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.